Clinical Trial Update: Molecular Imaging-based Dose Escalation in HPV Negative Patients With Locally Advanced SCC of the Oropharynx [NA]

View source ↗

Summary

Clinical trial update describing a study on molecular imaging-based dose escalation in HPV-negative locally advanced squamous cell carcinoma of the oropharynx; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Squamous Cell Carcinoma of the Oropharynx

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Head and Neck Cancer | NA | Status: UNKNOWN